pAF3

Protein Expression Prokaryotic cells - B. subtilis PHY US417

Experiment
Protein Expression Prokaryotic cells - B. subtilis PHY US417
Product
pAF3 from Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc
Manufacturer
Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc

Protocol tips

Protocol tips
B. subtilis was transformed according to the method of Anagnostopoulos and Spizizen (1961) with some modifications. To obtain naturally competent cells, B. subtilis 168 was grown in the Spizizen minimal medium (SMM): 80 mM K2HPO4, 45 mM KH2PO4, 15 mM (NH4)2SO4 and 3.8 mM Na3-citrate, supplemented with 5 mM MgSO4, 5 g l-1 glucose, 0.5 g l-1 tryptophan and 0.1 g l-1 casaminohydrolysate. For efficient DNA uptake of pAF3 and pMSP3535 (negative control) by B. subtilis, the plasmid DNA (1 μg) was linearized by NsiI and self-ligated in vitro to generate multimeric plasmidic forms. After dilution of competent cells (10-1) in SMM containing 20 mM MgCl2 and 5 g l-1 glucose, pAF3 or pMSP3535 plasmid DNA multimers were added, and the samples were incubated for 20 min at 37°C. Transformation mixtures were subsequently spread on LB agar containing erythromycin (5 μg ml-1).
Downstream tips
B. subtilis transformants were screened for the ability to produce phytase activity on LB agar supplemented with phytic acid (3 mM) by using the well-known two step counterstaining treatment (Bae et al. 1999). Colonies surrounded by clear zones were tested by PCR to confirm the presence of the phy US417 gene.

Publication protocol

B. subtilis was transformed according to the method of Anagnostopoulos and Spizizen (1961) with some modifications. To obtain naturally competent cells, B. subtilis 168 was grown in the Spizizen minimal medium (SMM): 80 mM K2HPO4, 45 mM KH2PO4, 15 mM (NH4)2SO4 and 3.8 mM Na3-citrate, supplemented with 5 mM MgSO4, 5 g l-1 glucose, 0.5 g l-1 tryptophan and 0.1 g l-1 casaminohydrolysate. For efficient DNA uptake of pAF3 and pMSP3535 (negative control) by B. subtilis, the plasmid DNA (1 μg) was linearized by NsiI and self-ligated in vitro to generate multimeric plasmidic forms. After dilution of competent cells (10-1) in SMM containing 20 mM MgCl2 and 5 g l-1 glucose, pAF3 or pMSP3535 plasmid DNA multimers were added, and the samples were incubated for 20 min at 37°C. Transformation mixtures were subsequently spread on LB agar containing erythromycin (5 μg ml-1). B. subtilis transformants were screened for the ability to produce phytase activity on LB agar supplemented with phytic acid (3 mM) by using the well-known two step counterstaining treatment (Bae et al. 1999). Colonies surrounded by clear zones were tested by PCR to confirm the presence of the phy US417 gene.

Full paper   Login or join for free to view the full paper.

Reviews

pAF3 from Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Start your discussion

Share your thoughts or question with experts in your field

Start a discussion

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing Protein Expression Prokaryotic cells - B. subtilis PHY US417 using pAF3 from Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc for pAF3 below.

We haven't found the manufacturer protocol for this product yet.

Videos

Check out videos that might be relevant for performing Protein Expression Prokaryotic cells - B. subtilis PHY US417 using pAF3 from Hichem Chouayekh, Laboratoire de Microorganismes et de Biomoléc. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Outsource your experiment

Fill out your contact details and receive price quotes in your Inbox

  Outsource experiment
Become shareholder Discussions About us Contact Privacy Terms